United Therapeutics (UTHR) Interest Coverage Ratio (2016 - 2025)
Historic Interest Coverage Ratio for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 129.5.
- United Therapeutics' Interest Coverage Ratio rose 28121.54% to 129.5 in Q3 2025 from the same period last year, while for Sep 2025 it was 61.46, marking a year-over-year increase of 14067.46%. This contributed to the annual value of 32.1 for FY2024, which is 6063.85% up from last year.
- Per United Therapeutics' latest filing, its Interest Coverage Ratio stood at 129.5 for Q3 2025, which was up 28121.54% from 49.93 recorded in Q2 2025.
- Over the past 5 years, United Therapeutics' Interest Coverage Ratio peaked at 129.5 during Q3 2025, and registered a low of 14.09 during Q1 2021.
- Over the past 5 years, United Therapeutics' median Interest Coverage Ratio value was 33.97 (recorded in 2024), while the average stood at 37.74.
- As far as peak fluctuations go, United Therapeutics' Interest Coverage Ratio crashed by 16929.4% in 2021, and later surged by 53498.82% in 2022.
- Over the past 5 years, United Therapeutics' Interest Coverage Ratio (Quarter) stood at 36.13 in 2021, then plummeted by 60.48% to 14.28 in 2022, then increased by 20.65% to 17.23 in 2023, then soared by 162.86% to 45.28 in 2024, then surged by 186.01% to 129.5 in 2025.
- Its Interest Coverage Ratio stands at 129.5 for Q3 2025, versus 49.93 for Q2 2025 and 62.75 for Q1 2025.